Increased adherence to ACOG diagnostic guidelines for HDP following a workshop in Bolivia, a LMIC.


Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 12 07 2023
revised: 14 08 2023
accepted: 15 09 2023
medline: 5 12 2023
pubmed: 2 10 2023
entrez: 1 10 2023
Statut: ppublish

Résumé

Hypertensive disorders of pregnancy (HDP) exert a heavy mortality burden in low- to middle-income countries (LMIC). ACOG revised HDP diagnostic guidelines to improve identifying pregnancies at greatest risk but whether they are used in LMIC is unknown. We held a workshop to review ACOG guidelines in La Paz, Bolivia (BO) and then reviewed prenatal, labor and delivery records for all HDP diagnoses and twice as many controls at its three largest delivery sites during the year before and the nine months after a workshop (n = 1376 cases, 2851 controls during the two periods). HDP diagnoses, maternal, and infant characteristics. Bolivian and ACOG criteria identified similar frequencies of gestational hypertension (GH) or eclampsia, but preeclampsia with severe features (sPE) was under- and preeclampsia without severe features (PE) over-reported during both periods. Increases occurred after the workshop in testing for proteinuria and the detection of abnormal laboratory values and severe hypertension in HDP women. Any adverse maternal outcome occurred more frequently after the workshop in women with BO PE or sPE diagnoses who met ACOG sPE criteria. Utilization of ACOG guidelines increased following the workshop and improved identification of PE or sPE pregnancies with adverse maternal outcomes. Continued use of a CLAP perinatal form recognizing HELLP as the only kind of sPE resulted in under-reporting of sPE. NIH TW010797, HD088590, HL138181.

Identifiants

pubmed: 37778281
pii: S2210-7789(23)00221-0
doi: 10.1016/j.preghy.2023.09.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-26

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD088590
Pays : United States
Organisme : FIC NIH HHS
ID : R21 TW010797
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lilian Toledo-Jaldin (L)

Hospital Materno-Infantil, Caja Nacional de Salud, La Paz, Bolivia.

Litzi Lazo-Vega (L)

Hospital Materno-Infantil, Caja Nacional de Salud, La Paz, Bolivia.

Laura Grau (L)

Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, United States.

Ian Lawrence (I)

University of Colorado Denver School of Medicine, Aurora, CO 80045, United States.

Alison Larrea-Alvarado (A)

Hospital Materno-Infantil, Caja Nacional de Salud, La Paz, Bolivia.

Rodrigo Mizutani (R)

Universidad Nuestra Señora de La Paz, Escuela de Medicina, La Paz, Bolivia.

Sebastian Rocabado (S)

Universidad Nuestra Señora de La Paz, Escuela de Medicina, La Paz, Bolivia.

Vikram Vasan (V)

Krieger School of Arts and Sciences, The Johns Hopkins University, Baltimore, MD, United States.

Mary Sammel (M)

Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, United States; Department of Obstetrics and Gynecology, University of Colorado Denver, Aurora, CO 80045, United States.

Colleen G Julian (CG)

Department of Medicine, University of Colorado Denver, Aurora, CO 80045, United States.

Lorna G Moore (LG)

Department of Obstetrics and Gynecology, University of Colorado Denver, Aurora, CO 80045, United States. Electronic address: Lorna.Moore@cuanschutz.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH